07 Jan 2001

Vigantoletten® 500 (Vigantoletten® 500/-1000 Tabletten) - Deutschland

Updated: 07 Jan 2001

Vigantoletten® 500 | -1000

Vorbeugung gegen Rachitis beim Sgl. Vorbeugung bei erkennbarem Risiko einer Vit.-D-Mangelerkrankung, Vorbeugung von Vit.-D-Mangelerscheinungen bei Verdauungsschwäche, z. B. durch chronische Darmerkrankungen, narbigen Umbau des Lebergewebes, Entfernung großer Teile des Magens oder Darms, Behandl. von Rachitis und Knochenerweichung durch Vit.-D-Mangel, unterstützende Behandl. bei Osteoporose.

Vigantoletten® 500 Description, Presentation and Dosage

Vigantoletten® 500 Description

Vigantoletten® 500 Drug Class Description

Andere Einzelstoffe

Vigantoletten® 500 Drug Description

1 Tbl. enth.: Colecalciferol 0,0125 mg/0,025 mg (entspr. 500 I.E./1000 I.E. Vit. D3).

Vigantoletten® 500 Generic Name

Vigantoletten® 500/-1000 Tabletten

Vigantoletten® 500 Presentation

Vigantoletten® 500 Presentation

Vigantoletten® 500/-1000

Vigantoletten® 500 Manufacturer

Merck

Related Learning Zones

Symptomatic Asthma Knowledge Centre and CME

Symptomatic Asthma Knowledge Centre and CME

Focusing on the lack of symptomatic control in patients with asthma, the new Symptomatic Asthma Learning Zone, consisting of a Disease Awareness section and an RCGP-accredited CME, is free to access for all epgonline.org members, and has been designed to provide them with the information they need to effectively manage the symptoms of their patients with asthma.

Type 2 Diabetes Knowledge Centre and CME

Type 2 Diabetes Knowledge Centre and CME

The Type 2 Diabetes Learning Zone comprises the Type 2 Diabetes Mellitus Knowledge Centre containing current epidemiology statistics, current diagnosis criteria from WHO and ADA, treatment options and latest guidelines; a Therapy Focus area compiling material on emerging insulin/incretin treatment combinations; and two free CME activities, which are the EACCME-accredited ‘Role of Newer Therapies for Type 2 Diabetes in Combination with Insulin’ (worth 1 CME credit) and ‘Best Practice in Type 2 Diabetes: Update on Incretin Therapies in Combination with Insulin’. 

Vigantoletten® 500 Dosage

Vigantoletten® 500 Adult Dosage

Siliciumdioxid, Maisstärke, Carboxymethylstärke-Natrium, Talkum, Glyceroltristearat, Cellulose, D-Mannitol, Gelatine, Saccharose, teilhydrierte Pflanzenöle (Sojaöl), 'alpha'-Tocopherol.

Vigantoletten® 500 Precautions, Reactions and Contraindications

Vigantoletten® 500 Special Precautions

Vigantoletten® 500 Special Precautions

V 15

Vigantoletten® 500 Adverse Reactions

Vigantoletten® 500 Adverse Reactions

V 15

Related Drugs - Rheumatology

Back to top